Inflammatory bowel disease (IBD) is a general term describing chronic, relapsing inflammation of the small or large intestine. Ongoing inflammation can lead to ulceration and, over time, the formation of scar tissue. The two primary forms of IBD are Crohn’s disease, which can affect any part of the gastrointestinal tract but commonly involves the small intestine, and ulcerative colitis, which affects the large intestine.

Nutrient Deficiencies in Inflammatory Bowel Disease

Patients with inflammatory bowel disease are frequently deficient in multiple nutrients. Contributing factors include impaired absorption, reduced appetite, restrictive diets, and nutrient depletion related to medication use.

A comprehensive review published in the Annual Review of Nutrition (1985; 5:463–484) reported that nutritional deficiencies were common among hospitalized patients with inflammatory bowel disease. The prevalence of deficiencies included:

  • Iron: ~40%

  • Vitamin B₁₂: ~48%

  • Folate: ~54–64%

  • Magnesium: ~14–33%

  • Potassium: ~6–14%

  • Vitamin A: ~21%

  • Vitamin C: ~12%

  • 25-hydroxyvitamin D: ~25–65%

  • Zinc: ~40–50%

Deficiencies in vitamin K, copper, and vitamin E were also reported.

Additional research published in the Scandinavian Journal of Gastroenterology (1979; 14:1019–1024) found low serum folate levels in 59% of patients with chronic inflammatory bowel disease.

Folate Status and Colorectal Cancer Risk

Long-standing inflammatory bowel disease is associated with an increased risk of colorectal cancer. Research published in Inflammatory Bowel Diseases (February 2008; 14(2):242–248) reported that folic acid deficiency was associated with a higher risk of colorectal cancer in patients with IBD. Patients who had both folate deficiency and elevated homocysteine levels exhibited substantially more cancerous lesions than patients without folate deficiency.

Vitamin Status and Disease Activity

Some vitamin deficiencies may contribute directly to disease severity, creating a cycle in which inflammation worsens nutrient status, and impaired nutrient status further exacerbates inflammation.

A study published in the American Journal of Gastroenterology (2003; 98(1):112–117) evaluated vitamin B₆ status in patients with inflammatory bowel disease. Vitamin B₆ levels were significantly lower in patients with IBD compared with healthy controls and were lowest during active disease flares. Lower vitamin B₆ levels were also associated with higher levels of inflammatory markers, including C-reactive protein (CRP).

Practical Challenges with Supplementation

Vitamin supplementation in patients with inflammatory bowel disease can be challenging. Some individuals experience symptom exacerbation when taking standard oral vitamin tablets. In these cases, liquid formulations may be better tolerated, although folic acid is not stable in liquid multivitamin preparations and often needs to be provided separately. In certain clinical situations, intravenous nutrient administration may be required.